Targeting the N -Methyl-d-Aspartate Receptor for Chronic Pain Management
Identifieur interne : 003381 ( Main/Exploration ); précédent : 003380; suivant : 003382Targeting the N -Methyl-d-Aspartate Receptor for Chronic Pain Management
Auteurs : Kim Fisher [Canada] ; Terence J. Coderre [Canada] ; Neil A. Hagen [Canada]Source :
- [ 0885-3924 ]
Abstract
A 1967–1999 MEDLINE search of published reports evaluating the role of the glutamate N-methyl-d-aspartate (NMDA) receptor in pain identified 378 animal studies and 132 human studies. There is convincing evidence in these studies that the NMDA receptor mediates prolonged nociceptive behaviors in animal models and various chronic pain symptoms in the clinical population. Administration of older compounds, such as ketamine, dextromethorphan, and amantadine, which are now known to act as NMDA receptor antagonists, have recently been shown to alleviate chronic pain. For years, the pharmaceutical industry has been attempting to produce novel compounds that modulate NMDA receptor activity; however, the adverse effects associated with this class of drugs have prevented their widespread clinical use. Collaborative studies between basic researchers, clinical scientists, and clinicians are needed to delineate characteristics of NMDA receptor antagonism that predict optimal analgesic activity and an acceptable toxicity profile in patients with chronic pain.
Url:
DOI: 10.1016/S0885-3924(00)00213-X
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002099
- to stream Istex, to step Curation: 002099
- to stream Istex, to step Checkpoint: 001101
- to stream Main, to step Merge: 003909
- to stream Main, to step Curation: 003381
Le document en format XML
<record><TEI wicri:istexFullTextTei="no"><teiHeader><fileDesc><titleStmt><title>Targeting the N -Methyl-d-Aspartate Receptor for Chronic Pain Management</title><author><name sortKey="Fisher, Kim" sort="Fisher, Kim" uniqKey="Fisher K" first="Kim" last="Fisher">Kim Fisher</name></author><author><name sortKey="Coderre, Terence J" sort="Coderre, Terence J" uniqKey="Coderre T" first="Terence J" last="Coderre">Terence J. Coderre</name></author><author><name sortKey="Hagen, Neil A" sort="Hagen, Neil A" uniqKey="Hagen N" first="Neil A" last="Hagen">Neil A. Hagen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8D6863DDC4542AB3C52B338D50C689FF18421BB0</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0885-3924(00)00213-X</idno><idno type="url">https://api-v5.istex.fr/document/8D6863DDC4542AB3C52B338D50C689FF18421BB0/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002099</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002099</idno><idno type="wicri:Area/Istex/Curation">002099</idno><idno type="wicri:Area/Istex/Checkpoint">001101</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001101</idno><idno type="wicri:doubleKey">0885-3924:2000:Fisher K:targeting:the:n</idno><idno type="wicri:Area/Main/Merge">003909</idno><idno type="wicri:Area/Main/Curation">003381</idno><idno type="wicri:Area/Main/Exploration">003381</idno></publicationStmt><sourceDesc><biblStruct><analytic><author><name sortKey="Fisher, Kim" sort="Fisher, Kim" uniqKey="Fisher K" first="Kim" last="Fisher">Kim Fisher</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Clinical Neurosciences, Tom Baker Cancer Center, Calgary, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author><author><name sortKey="Coderre, Terence J" sort="Coderre, Terence J" uniqKey="Coderre T" first="Terence J" last="Coderre">Terence J. Coderre</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Pain Mechanisms Laboratory, Université de Montréal, Montréal, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author><author><name sortKey="Hagen, Neil A" sort="Hagen, Neil A" uniqKey="Hagen N" first="Neil A" last="Hagen">Neil A. Hagen</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Clinical Neurosciences, Tom Baker Cancer Center, Calgary, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author></analytic><series><idno type="ISSN">0885-3924</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3924</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 1967–1999 MEDLINE search of published reports evaluating the role of the glutamate N-methyl-d-aspartate (NMDA) receptor in pain identified 378 animal studies and 132 human studies. There is convincing evidence in these studies that the NMDA receptor mediates prolonged nociceptive behaviors in animal models and various chronic pain symptoms in the clinical population. Administration of older compounds, such as ketamine, dextromethorphan, and amantadine, which are now known to act as NMDA receptor antagonists, have recently been shown to alleviate chronic pain. For years, the pharmaceutical industry has been attempting to produce novel compounds that modulate NMDA receptor activity; however, the adverse effects associated with this class of drugs have prevented their widespread clinical use. Collaborative studies between basic researchers, clinical scientists, and clinicians are needed to delineate characteristics of NMDA receptor antagonism that predict optimal analgesic activity and an acceptable toxicity profile in patients with chronic pain.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Fisher, Kim" sort="Fisher, Kim" uniqKey="Fisher K" first="Kim" last="Fisher">Kim Fisher</name></noRegion><name sortKey="Coderre, Terence J" sort="Coderre, Terence J" uniqKey="Coderre T" first="Terence J" last="Coderre">Terence J. Coderre</name><name sortKey="Hagen, Neil A" sort="Hagen, Neil A" uniqKey="Hagen N" first="Neil A" last="Hagen">Neil A. Hagen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003381 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003381 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8D6863DDC4542AB3C52B338D50C689FF18421BB0
|texte= Targeting the N -Methyl-d-Aspartate Receptor for Chronic Pain Management
}}
| This area was generated with Dilib version V0.6.29. |  |